Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2005
10/26/2005EP1588726A1 Drug/drug delivery systems for the prevention and treatment of vascular disease
10/26/2005EP1588718A1 Gene therapy of hepatocyte growth factor to enhance muscular and cutaneous flap survival
10/26/2005EP1588709A1 Vitamin comprising pyroloquinoline quinone and use thereof
10/26/2005EP1588708A1 Process for producing coated preparation
10/26/2005EP1588707A1 Stable solid medicinal composition for oral administration
10/26/2005EP1588706A2 Use of AT1 receptor antagonists or AT2 receptor modulator for the treatment of conditions or diseases associated with the increase of AT1 or AT2 receptors.
10/26/2005EP1588705A1 Use of coumarin derivatives
10/26/2005EP1588704A1 Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders
10/26/2005EP1588703A1 Fatigue reducing agent
10/26/2005EP1588702A1 Azalide antibiotics for the topical treatment or prevention of ocular infections
10/26/2005EP1588701A2 Rapidly-decomposing dosage form for releasing nicotine in the oral cavity or in bodily cavities
10/26/2005EP1588698A2 A process for the production and screening of materials for use in pharmaceutical aerosol formulations
10/26/2005EP1588629A1 Matrix-forming composition containing pectin
10/26/2005EP1587945A2 Hydroxyphenyl cross-linked macromolecular network and applications thereof
10/26/2005EP1587906A2 Vesicant treatment with phenyl-phenyl type vitamin d receptor modulators
10/26/2005EP1587905A2 Vesicant treatment with phenyl-thiophene type vitamin d receptor modulators
10/26/2005EP1587834A2 Uses of mammalian cytokine; related reagents
10/26/2005EP1587821A2 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
10/26/2005EP1587818A2 17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators
10/26/2005EP1587812A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease
10/26/2005EP1587811A1 Thienopyridazinones and their use in modulation of autoimmune disease
10/26/2005EP1587809A1 Novel compounds
10/26/2005EP1587805A1 Paharmaceutical process and compounds prepared thereby
10/26/2005EP1587804A1 Androgen receptor antagonists
10/26/2005EP1587800A1 Thiazole derivatives and their use as vap-1 inhibitors
10/26/2005EP1587799A1 Benzoxazole derivatives and their use as adenosine receptor ligands
10/26/2005EP1587798A2 Geminally di-substituted nsaid derivatives as abeta 42 lowering agents
10/26/2005EP1587796A1 Saturated quinoxaline derivatives and their use as metabotropic glutamate receptor ligands
10/26/2005EP1587795A1 N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as cgrp-antagonists for treating a headache
10/26/2005EP1587792A1 Stable amorphous amlodipine camsylate, process for preparing same and composition for oral administration thereof
10/26/2005EP1587791A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
10/26/2005EP1587789A2 Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
10/26/2005EP1587783A2 Cycloalkyl containing anilide ligands for the thyroid receptor
10/26/2005EP1587584A1 Pharmaceutical combination for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases
10/26/2005EP1587574A2 SELECTIVE 11b-HSD INHIBITORS AND METHODS FOR USE THEREOF
10/26/2005EP1587553A1 Quaternary ammonium esters for disinfection and preservation
10/26/2005EP1587547A2 Amyloid-binding, metal-chelating agents
10/26/2005EP1587535A2 Title of the invention n-cyclohexylaminocarbonyl benzenesulfonamide derivatives
10/26/2005EP1587527A1 Amino acid derived prodrugs of propofol, compositions and uses thereof
10/26/2005EP1587525A2 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus
10/26/2005EP1587522A1 Attaining sexual wellness and health of the sexual vascular system with proanthocyanidins
10/26/2005EP1587519A2 Treatment of cancer with 2-deoxyglucose
10/26/2005EP1587518A2 Antineoplastic ether lipid compounds with modifications at the sn-3 carbon
10/26/2005EP1587517A1 Anti-protozoal compositions comprising diclazuril
10/26/2005EP1587515A1 Biologic skin repair and enhancement
10/26/2005EP1587514A1 A rapid-acting pharmaceutical composition
10/26/2005EP1587513A2 Antineoplastic ether lipid compounds with modifications at the sn-2 carbon
10/26/2005EP1587512A2 Pde4 inhibitors for the treatment of neoplasms of lymphoid cells
10/26/2005EP1587511A2 Treatment of diseases with alpha-7 nach receptor full agonists
10/26/2005EP1587510A1 Method for treating ischemic stroke with melatonin
10/26/2005EP1587509A2 Androgen receptor antagonists
10/26/2005EP1587508A1 Therapeutic use of acylglycerols and the nitrogen- and sulphur-containing analogues thereof
10/26/2005EP1587507A1 A method of treatment or prophylaxis of symptoms of herpes viral infection
10/26/2005EP1587506A2 Administration of capsaicinoids
10/26/2005EP1587505A2 Wound and skin care compositions
10/26/2005EP1587499A1 Nanoparticulate topiramate formulations
10/26/2005EP1587498A1 Powder pharmaceutical compositions
10/26/2005EP1587486A2 Care or make-up composition comprising a 2-alkylideneaminooxyacetamide, its use for stimulating the growth of the hair or eyelashes and/or slowing down their loss
10/26/2005EP1587484A2 Method of treating angiogenic tissue growth
10/26/2005EP1587483A2 Methods for modulating an inflammatory response
10/26/2005EP1587482A2 Anti-inflammatory compositions and uses thereof
10/26/2005EP1587481A2 Sensitive proteasome sensor constructs and methods for their design and use
10/26/2005EP1587480A2 Polyhydroxylated pyrrolizidine
10/26/2005EP1587479A2 Pharmaceutical combination for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases
10/26/2005EP1587477A2 Odorless formulation for treating mucosal discontinuities
10/26/2005EP1587474A2 Fluoroalkoxy-substituted 1, 3-dihydro-isoindolyl compounds and their pharmaceutical uses
10/26/2005EP1587473A2 Thiosemicarbazones as anti-virals and immunopotentiators
10/26/2005EP1587470A2 Improved formulations for transmucosal vaginal delivery of bisphosphonates
10/26/2005EP1587440A2 Drug-coated stents and methods of use therefor
10/26/2005EP1534072A4 Anthelmintic oral homogeneous veterinary pastes
10/26/2005EP1501859B1 17a-FLUOROALKYL-11BETA-BENZALDOXIME-STEROIDS, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING SAID STEROIDS AND THE USE THEREOF IN THE PRODUCTION OF MEDICAMENTS
10/26/2005EP1444264A4 Methods and materials for targeting and affecting selected cells
10/26/2005EP1441683A4 Trisubstituted triazine compounds, and methods for making an using the compounds, which have antitubulin activity
10/26/2005EP1440071B1 Imidazopyridine compounds as 5-ht 4? receptor modulators
10/26/2005EP1430056B1 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives for neurodegenerative disorders
10/26/2005EP1423109B1 Compositions comprising pectin and ascorbic acid
10/26/2005EP1397354B1 Imidazole-2-carboxamide derivatives as raf kinase inhibitors
10/26/2005EP1397133B1 Rapid onset formulation
10/26/2005EP1390368B1 Disubstituted 7,9-guaninium halides as telomerase inhibitors
10/26/2005EP1381607B1 Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepine-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
10/26/2005EP1368001B1 Pharmaceutical formulation comprising bicalutamide
10/26/2005EP1363641B1 Progestin co-micronized with a surfactant, pharmaceutical composition comprising the same, methods for making same and uses thereof
10/26/2005EP1361881B1 Steroid hormone products and methods for preparing them
10/26/2005EP1341766B1 Imidazolone derivatives for the treatment of viral diseases
10/26/2005EP1328236A4 Methods of decreasing or preventing pain using spicamycin derivatives
10/26/2005EP1299099B1 Novel use of (r)-(-)-2- 5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts
10/26/2005EP1289965B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
10/26/2005EP1280571B1 Delivery devices for treatment of vascular disease
10/26/2005EP1265618B1 Anaesthetic compositions comprising alfaxalone
10/26/2005EP1246626B1 Use of a cyclic ether for the preparation of medicaments affecting glucose tolerance
10/26/2005EP1242048B1 Inhalation particles
10/26/2005EP1212081B1 Use of ace inhibitors in the prevention of congestive heart failure
10/26/2005EP1185277B1 Use of FXR synthetic ligands for the treatment of diseseas linked to cholesterol imbalance and colon cancer
10/26/2005EP1183229B1 Glucagon antagonists/inverse agonists
10/26/2005EP1169059B1 Docetaxel in combination with rhumab her2 for the treatment of cancers
10/26/2005EP1165035B1 Cosmetic compositions containing at least one substance for increasing the functionality and/or expression of cd44 membrane receptors of skin cells
10/26/2005EP1163234B1 Pharmaceutical formulations with improved aqueous solubility
10/26/2005EP1159455B1 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE
10/26/2005EP1140000B1 Cosmetic or dermatological composition containing an active principle stimulating hsp 32 protein synthesis in the skin and cosmetic treatment method
10/26/2005EP1137426B1 Breast cancer treatment using natural plant essential oils
1 ... 4491 4492 4493 4494 4495 4496 4497 4498 4499 4500 4501 4502 4503 4504 4505 4506 4507 4508 4509 4510 4511 ... 7860